Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$534K Sell
3,433
-366
-10% -$65.7K 0.01% 900
2025
Q4
$698K Buy
3,799
+143
+4% +$27.1K 0.01% 772
2025
Q3
$691K Buy
3,656
+505
+16% +$87.9K 0.01% 775
2025
Q2
$497K Buy
3,151
+454
+17% +$67.1K 0.01% 896
2025
Q1
$364K Sell
2,697
-1,641
-38% -$229K 0.01% 1001
2024
Q4
$624K Buy
4,338
+844
+24% +$140K 0.01% 786
2024
Q3
$577K Buy
3,494
+378
+12% +$57.2K 0.01% 832
2024
Q2
$454K Buy
3,116
+378
+14% +$52.8K 0.01% 858
2024
Q1
$359K Buy
+2,738
New +$326K 0.01% 485

Other funds holding LDOS

Choreo LLC's LDOS Position: Q1 2026 in Review

Choreo LLC reduced its Leidos (LDOS) stake by 9.6% in Q1 2026, selling an estimated $65.7K and leaving 3,433 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #900.

Choreo LLC first reported a position in LDOS in Q1 2024 and has held it in 9 quarters since. The position peaked at $698K in Q4 2025. 897 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.

  • Choreo LLC held 3,433 shares of Leidos worth $534K as of Q1 2026.
  • Choreo LLC sold 366 Leidos shares in Q1 2026, an estimated $65.7K.
  • Leidos made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #900 holding.
  • Choreo LLC first reported a position in Leidos in Q1 2024 and has held it in 9 quarters since.
  • Choreo LLC's Leidos position peaked at $698K in Q4 2025.
  • 897 funds tracked by Wall St. Rank held Leidos as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.